EN
HI
Summary
As of 26 Aug, 2026, Neuland Laboratories stock price is ₹23262. During the trading session, the stock has moved between an intraday low of ₹22978.00 and an intraday high of ₹23434.00. Over the last 52 weeks, Neuland Laboratories has traded between ₹11500.00 and ₹23881.00.
The stock has recorded a trading volume of 10,121 shares, with a market capitalization of ₹12829889. Its Average Traded Price (ATP) is ₹23274.82, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹23262.00.
Neuland Laboratories has an upper circuit limit of ₹27537.00 and a lower circuit limit of ₹18359.00. The total value traded stands at ₹23.56 CR, and the delivery percentage for the day is 46.92%.
The stock is currently traded with a market lot size of 1. Neuland Laboratories also offers a dividend yield of 0.15%.
Neuland Laboratories share price chart
Neuland Laboratories Share Key Metrics
Volume
10121.00
Market Cap
29442.03 CR
LTQ@LTP
25@23262.00
ATP
23274.82
Var Margin
21.59 %
Circuit Range
18359-27537
Delivery %
46.92 %
Value
23.56 CR
ASM/GSM
No
Market Lot
1
Neuland Laboratories Fundamentals
P/E Ratio
59.09
P/B Ratio
14.55
Div. Yield
0.15
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Neuland Laboratories Resistance and Support
Pivot 22876.33
Resistance
First Resistance
23115.66
Second Resistance
23283.33
Third Resistance
23522.66
Support
First Support
22708.66
Second Support
22469.33
Third Support
22301.66
Neuland Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 26 2026 | 23070 | 23262 | 1.37% | 23434 | 22978 |
| Tue Aug 25 2026 | 22905 | 22948 | 0.19% | 23044 | 22637 |
| Mon Aug 24 2026 | 23399 | 22905 | -1.70% | 23399 | 22834 |
Neuland Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-10 | Quarterly Results |
| 2024-11-06 | Quarterly Results |
Neuland Laboratories News
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Credit Rating
Neuland Labs long-term credit rating of CRISIL A+ was reaffirmed by CRISIL Ratings, and its outlook was revised to 'Positive', indicating improved creditworthiness. The short-term rating of CRISIL A1 was also reaffirmed.
Aug 25 2026 20:39:37
Neuland Laboratories Ltd - 524558 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Malabar India Fund Limited sold 2,72,634 equity shares, representing 2.12% of Neuland Laboratories' total share capital, reducing its holding from 7.18% to 5.06%. The transactions occurred in the open market.
Aug 17 2026 14:03:18
Read More
Neuland Laboratories Management
| Name | Position |
|---|---|
| Davuluri Rama Mohan Rao | Chairman |
| Davuluri Sucheth Rao | Vice Chairman |
Neuland Laboratories Similar Stocks
Emcure Pharmaceuticals Ltd.
1856.50
9.60 (0.52%)
Krishna Institute of Medical Sciences Ltd
769.25
-3.25 (0.42%)
Dr. Lal Pathlabs Ltd.
1942.50
28.80 (1.50%)
Wockhardt Ltd.
1912.00
12.40 (0.65%)
Sai Life Sciences Ltd.
1464.30
8.80 (0.60%)
Piramal Pharma Ltd.
212.32
4.61 (2.22%)
Acutaas Chemicals Ltd.
3275.40
-38.00 (1.15%)
Pfizer Ltd.
4775.60
17.60 (0.37%)
Granules India Ltd.
837.70
-8.25 (0.98%)
Caplin Point Laboratories Ltd.
2516.50
44.70 (1.81%)
Neuland Laboratories FAQs
The Buying Price of Neuland Laboratories share is 23262 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Neuland Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Neuland Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Neuland Laboratories shares is 59.09. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Neuland Laboratories shares is 14.55. Useful to assess the stock's value relative to its book value.
To assess Neuland Laboratories’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Neuland Laboratories is 29442.03 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Neuland Laboratories share price is 23881.00 & 11500.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Neuland Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NEULANDLAB
Or Download Choice FinX App
Invest in NEULANDLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade